Topiramate
- 1 lab in 1 country
- Funder: Indian Council of Medical Research
- Human trial1
Outcomes
1QRISK3
upin humans1
1 study
QRISK3
upin humans1
Topiramate improves QRISK3 in humans (MD = 0.61 (0.02 to 1.21)).
Human trialin patients of schizophrenia with metabolic syndrome on atypical antipsychotics50 mg/dayeight weeks
European archives of psychiatry and clinical neuroscience4 Aug 2026
Latest
3 in 12 monthsEuropean Archives of Psychiatry and Clinical Neuroscience
Efficacy and safety of add-on topiramate vs. metformin on cardiometabolic profile in patients of schizophrenia on atypical antipsychotics with metabolic syndrome: an active-controlled, rater-blinded, parallel-design randomized controlled trial
Randomised trial in 60 peopleSchizophrenia
AHA Scientific Sessions 2025 Abstract
Real-World Effectiveness of GLP-1 Receptor Agonists on Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF).
Study in peopleInterventions
ADA Scientific Sessions 2025 Abstract
BMI Regain and Blood-Pressure Change after Discontinuation of Antiobesity Agents
Study in peopleInterventions